Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rafael Holdings, Inc. Class B Common Stock (NY: RFL )

1.670 UNCHANGED
Streaming Delayed Price Updated: 2:59 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 80,471
Open 1.659
Bid (Size) 1.660 (1)
Ask (Size) 1.670 (65)
Prev. Close 1.670
Today's Range 1.580 - 1.670
52wk Range 1.290 - 2.500
Shares Outstanding 100
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the... 
From Rafael Holdings, Inc.
Via GlobeNewswire
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire

Performance

YTD
-5.11%
-5.11%
1 Month
-15.66%
-15.66%
3 Month
-19.32%
-19.32%
6 Month
-8.24%
-8.24%
1 Year
-2.34%
-2.34%

More News

Read More
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
RFL Stock Earnings: Rafael Holdings Reported Results for Q3 2024
Via InvestorPlace
RFL Stock Earnings: Rafael Holdings Reported Results for Q1 2024
Via InvestorPlace
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, SMC, COFS, RFL on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, RVNC, ARC, RFL on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COFS, ARC, NBY, RFL on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CrossFirst Bankshares, Inc. (Nasdaq - CFB), Arch Resources, Inc. (NYSE - ARCH), Cyclo Therapeutics, Inc. (Nasdaq - CYTH), Vector Group Ltd. (NYSE - VGR)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CrossFirst Bankshares, Inc. (Nasdaq - CFB), Arch Resources, Inc. (NYSE - ARCH), Cyclo Therapeutics, Inc. (Nasdaq - CYTH), Vector Group Ltd. (NYSE - VGR)
From Brodsky & Smith LLC
Via GlobeNewswire
RFL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Rafael Holdings, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement
From Cyclo Therapeutics, Inc.
Via Business Wire
Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement
From Rafael Holdings, Inc.; Cyclo Therapeutics
Via GlobeNewswire
Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1
From Cyclo Therapeutics, Inc.
Via Business Wire
Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
From Cyclo Therapeutics, Inc.
Via Business Wire
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Cyclo Therapeutics Reports Second Quarter 2023 Financial Results
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.
From Cyclo Therapeutics, Inc.
Via Business Wire
Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
From Rafael Holdings, Inc.
Via GlobeNewswire
Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement
From Cyclo Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.